Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NBI-56418 in Endometriosis

NCT00109512 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00109512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NBI-56418 in Endometriosis
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
June 30, 2006
Enrollment
76 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis